151 related articles for article (PubMed ID: 986052)
1. Sites of action of morphine involved in the development of physical dependence in rats. II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various brain areas.
Laschka E; Teschemacher H; Mehraein P; Herz A
Psychopharmacologia; 1976 Mar; 46(2):141-7. PubMed ID: 986052
[TBL] [Abstract][Full Text] [Related]
2. Sites of action of morphine involved in the development of physical dependence in rats. I. Comparison of precipitated morphine withdrawal after intraperitoneal and intraventricular injection of morphine antagonists.
Laschka E; Herz A; Bläsig J
Psychopharmacologia; 1976 Mar; 46(2):133-9. PubMed ID: 986051
[TBL] [Abstract][Full Text] [Related]
3. Sites of action of morphine involved in the development of physical dependence in rats. III. Autoradiographic studies.
Laschka E; Herz A
Psychopharmacology (Berl); 1977 Jun; 53(1):33-7. PubMed ID: 196306
[TBL] [Abstract][Full Text] [Related]
4. An intraventricular infusion model for inducing morphine dependence in rats: quantitative assessment of precipitated withdrawal.
Huffman RD; Simmons KE; Lum JT
Behav Neurosci; 1985 Oct; 99(5):861-80. PubMed ID: 3843305
[TBL] [Abstract][Full Text] [Related]
5. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
Sinchaisuk S; Ho IK; Rockhold RW
Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
[TBL] [Abstract][Full Text] [Related]
6. Proceedings: Site of action of morphine in the development of physical dependence in rats.
Laschka E; Teschemacher H; Mehraein D; Herz A
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R54. PubMed ID: 4276597
[No Abstract] [Full Text] [Related]
7. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.
Frenois F; Cador M; Caillé S; Stinus L; Le Moine C
Eur J Neurosci; 2002 Oct; 16(7):1377-89. PubMed ID: 12405997
[TBL] [Abstract][Full Text] [Related]
8. Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved.
Georges F; Stinus L; Le Moine C
Eur J Neurosci; 2000 Dec; 12(12):4475-86. PubMed ID: 11122358
[TBL] [Abstract][Full Text] [Related]
9. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS
Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612
[TBL] [Abstract][Full Text] [Related]
10. Evidence that 5-hydroxytryptamine in the forebrain is involved in naloxone-precipitated jumping in morphine-dependent rats.
Cervo L; Romandini S; Samanin R
Br J Pharmacol; 1983 Aug; 79(4):993-6. PubMed ID: 6686075
[TBL] [Abstract][Full Text] [Related]
11. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats.
Nakagawa T; Yamamoto R; Fujio M; Suzuki Y; Minami M; Satoh M; Kaneko S
Neuroscience; 2005; 134(1):9-19. PubMed ID: 15939543
[TBL] [Abstract][Full Text] [Related]
13. Central sites of naloxone-precipitated shaking in the anesthetized, morphine-dependent rat.
Wei E; Sigel SS; Loh HH; Way EL
J Pharmacol Exp Ther; 1975 Dec; 195(3):480-7. PubMed ID: 1238555
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
Lu L; Liu D; Ceng X; Ma L
Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
[TBL] [Abstract][Full Text] [Related]
15. Dependence and withdrawal following intracerebroventricular and systemic morphine administration: functional anatomy and behavior.
Adams RE; Wooten GF
Brain Res; 1990 Jun; 518(1-2):6-10. PubMed ID: 2390728
[TBL] [Abstract][Full Text] [Related]
16. Relative involvement of supraspinal and spinal mu opioid receptors in morphine dependence in mice.
Miyamoto Y; Takemori AE
Life Sci; 1993; 52(12):1039-44. PubMed ID: 8383266
[TBL] [Abstract][Full Text] [Related]
17. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
[TBL] [Abstract][Full Text] [Related]
18. Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.
Le Guen S; Gestreau C; Besson JM
Eur J Neurosci; 2003 Jun; 17(11):2425-37. PubMed ID: 12814374
[TBL] [Abstract][Full Text] [Related]
19. The role of afferent inputs to supraoptic nucleus oxytocin neurons during naloxone-precipitated morphine withdrawal in the rat.
Murphy NP; Onaka T; Brown CH; Leng G
Neuroscience; 1997 Sep; 80(2):567-77. PubMed ID: 9284358
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus.
Hong M; Milne B; Jhamandas K
Brain Res; 1993 Sep; 623(1):131-41. PubMed ID: 8221081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
